Unitil Q3 EPS $0.00, Sales $98.10M Beat $95.67M Estimate

Unitil (NYSE:UTL) reported quarterly sales of $98.10 million which beat the analyst consensus estimate of $95.67 million by 2.54 percent. This is a 12.24 percent increase over sales of $87.40 million the same period

byBill Haddad

November 2, 2021

1 minute read

Proassurance Q2 EPS $0.49 Up From $(0.60) YoY, Sales $238.99M Up From $207.29M YoY

By Benzinga Newsdesk

Today, 3:47 AM

Proassurance (NYSE:PRA) reported quarterly earnings of $0.49 per share. This is a 181.67 percent increase over losses of $(0.60) per share from the same period last year. The company reported $238.99 million in sales

PRA

Morgan Stanley Maintains Equal-Weight on Nutanix, Lowers Price Target to $32

By Benzinga Newsdesk

Today, 3:47 AM

Morgan Stanley maintains Nutanix (NASDAQ:NTNX) with a Equal-Weight and lowers the price target from $38 to $32.

NTNX

UBS Initiates Coverage On Calumet Specialty with Neutral Rating, Announces Price Target of $15.7

By Benzinga Newsdesk

Today, 3:47 AM

UBS analyst Manav Gupta initiates coverage on Calumet Specialty (NASDAQ:CLMT) with a Neutral rating and announces Price Target of $15.7.

CLMT

EDAP Priced ~2.66M ADS Public Offering @$7.50/ADS

By Charles Gross

Today, 3:47 AM

EDAP TMS S.A. (NASDAQ: EDAP) announced that the price of its public offering of its American Depositary Shares ("ADSs"), which commenced on September 22, 2022, has been set today at $7.50 per ADS, before underwriting discounts and commissions, and that the number of offered ADSs is 2,666,667.

EDAP

Unitil Q3 EPS $0.00, Sales $98.10M Beat $95.67M Estimate

Related Posts

Proassurance Q2 EPS $0.49 Up From $(0.60) YoY, Sales $238.99M Up From $207.29M YoY

Morgan Stanley Maintains Equal-Weight on Nutanix, Lowers Price Target to $32

UBS Initiates Coverage On Calumet Specialty with Neutral Rating, Announces Price Target of $15.7

EDAP Priced ~2.66M ADS Public Offering @$7.50/ADS